Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Meyer

Showing results (421-430 of 510) with videos related to

Pageof 51
Sort By:
Endocrine-Related Cancer|July 15, 2016
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumoursAlexa Childs, Amy Kirkwood, Julien Edeline, et al.
The Journal of Clinical Investigation|June 1, 2021
Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1Christian Meisel, Bengisu Akbil, Tim Meyer, et al.
Journal of Molecular Biology|July 29, 2008
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virusHeide Kogelberg, Berend Tolner, Gareth J Thomas, et al.
JAMA Oncology|October 5, 2023
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical TrialShukui Qin, Masatoshi Kudo, Tim Meyer, et al.
Hepatology (Baltimore, Md.)|May 21, 2020
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus ConferenceJosep M Llovet, Augusto Villanueva, Jorge A Marrero, et al.
Archives of General Psychiatry|February 4, 2010
Hippocampal plasticity in response to exercise in schizophreniaFrank-Gerald Pajonk, Thomas Wobrock, Oliver Gruber, et al.
Frontiers in Genetics|November 8, 2021
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health SystemPawel Mroz, Stephen Michel, Josiah D Allen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.
British Journal of Cancer|October 8, 2021
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin gradeRobin Kate Kelley, Rebecca Miksad, Irfan Cicin, et al.
Neuroendocrinology|September 20, 2020
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 PatientsAimee R Hayes, Ingrid Y F Mak, Nicholas Evans, et al.
Pageof 51

Showing results (421-430 of 510) with videos related to

Sort By:
Pageof 51
Endocrine-Related Cancer|July 15, 2016
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumoursAlexa Childs, Amy Kirkwood, Julien Edeline, et al.
The Journal of Clinical Investigation|June 1, 2021
Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1Christian Meisel, Bengisu Akbil, Tim Meyer, et al.
Journal of Molecular Biology|July 29, 2008
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virusHeide Kogelberg, Berend Tolner, Gareth J Thomas, et al.
JAMA Oncology|October 5, 2023
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical TrialShukui Qin, Masatoshi Kudo, Tim Meyer, et al.
Hepatology (Baltimore, Md.)|May 21, 2020
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus ConferenceJosep M Llovet, Augusto Villanueva, Jorge A Marrero, et al.
Archives of General Psychiatry|February 4, 2010
Hippocampal plasticity in response to exercise in schizophreniaFrank-Gerald Pajonk, Thomas Wobrock, Oliver Gruber, et al.
Frontiers in Genetics|November 8, 2021
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health SystemPawel Mroz, Stephen Michel, Josiah D Allen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.
British Journal of Cancer|October 8, 2021
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin gradeRobin Kate Kelley, Rebecca Miksad, Irfan Cicin, et al.
Neuroendocrinology|September 20, 2020
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 PatientsAimee R Hayes, Ingrid Y F Mak, Nicholas Evans, et al.
Pageof 51